| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | -2.14% | -0.94% | -1.20% | -1.20% | — |
| 14d | 1 | +100.00% | -7.62% | -3.54% | -4.08% | -4.08% | — |
| 30d | 1 | +100.00% | -0.71% | +0.40% | -1.12% | -1.12% | — |
| 60d | 1 | +0.00% | +2.86% | +8.93% | -6.07% | -6.07% | — |
| 90d | 1 | +100.00% | -6.43% | +8.90% | -15.33% | -15.33% | — |
| 180d | 1(1 pending) | — | — | — | — | — | — |
| 1y | 1(1 pending) | — | — | — | — | — | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| AQST AQUESTIVE THERAPEUTICS, INC. | SALE SVP, Regulatory Affairs | 1,667 | $4.17 | $7.0K | 273,200 | May 15, 2026 | May 19, 2026 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | SALE SVP, Regulatory Affairs | 25,311 | $4.17 | $105.6K | 274,867 | Mar 10, 2026 | Mar 11, 2026 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 75,000 | $4.29 | $321.8K | 75,000 | Mar 9, 2026 | Mar 11, 2026 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 300,178 | Mar 9, 2026 | Mar 11, 2026 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | SALE SVP, Regulatory Affairs | 2,083 | $5.93 | $12.4K | 200,178 | Dec 2, 2025 | Dec 4, 2025 ↗ | View → |
| AQST AQUESTIVE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 20,000 | — | — | 202,261 | May 15, 2025 | May 15, 2025 ↗ | View → |